Targeting poly (ADP) ribose polymerase I (PARP-1) interacting proteins for cancer treatment (2008)
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FFCLRP
Subjects: NUCLEOTÍDEOS, NEOPLASIAS (TRATAMENTO), GENÉTICA
ABNT
SAKAMOTO-HOJO, Elza Tiemi e BALAJEE, Adayabalam S. Targeting poly (ADP) ribose polymerase I (PARP-1) interacting proteins for cancer treatment. Anti-Cancer Agents in Medicinal Chemistry, v. 8, n. 4, p. 402-416, 2008Tradução . . Acesso em: 13 nov. 2024.APA
Sakamoto-Hojo, E. T., & Balajee, A. S. (2008). Targeting poly (ADP) ribose polymerase I (PARP-1) interacting proteins for cancer treatment. Anti-Cancer Agents in Medicinal Chemistry, 8( 4), 402-416.NLM
Sakamoto-Hojo ET, Balajee AS. Targeting poly (ADP) ribose polymerase I (PARP-1) interacting proteins for cancer treatment. Anti-Cancer Agents in Medicinal Chemistry. 2008 ; 8( 4): 402-416.[citado 2024 nov. 13 ]Vancouver
Sakamoto-Hojo ET, Balajee AS. Targeting poly (ADP) ribose polymerase I (PARP-1) interacting proteins for cancer treatment. Anti-Cancer Agents in Medicinal Chemistry. 2008 ; 8( 4): 402-416.[citado 2024 nov. 13 ]